
Alana Harris Dent
Examiner (ID: 7014)
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 1512 |
| Issued Applications | 526 |
| Pending Applications | 351 |
| Abandoned Applications | 660 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5289931
[patent_doc_number] => 20090022661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/172626
[patent_app_country] => US
[patent_app_date] => 2008-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13410
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022661.pdf
[firstpage_image] =>[orig_patent_app_number] => 12172626
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172626 | Cancerous disease modifying antibodies | Jul 13, 2008 | Abandoned |
Array
(
[id] => 9060110
[patent_doc_number] => 08546546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Anti-Muc 17 antibody'
[patent_app_type] => utility
[patent_app_number] => 12/667595
[patent_app_country] => US
[patent_app_date] => 2008-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 15397
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12667595
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/667595 | Anti-Muc 17 antibody | Jul 2, 2008 | Issued |
Array
(
[id] => 5453500
[patent_doc_number] => 20090069537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Treatment Of Disease By Inducing Cell Apoptosis'
[patent_app_type] => utility
[patent_app_number] => 12/166907
[patent_app_country] => US
[patent_app_date] => 2008-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 23186
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069537.pdf
[firstpage_image] =>[orig_patent_app_number] => 12166907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/166907 | Treatment of disease by inducing cell apoptosis | Jul 1, 2008 | Issued |
Array
(
[id] => 4599033
[patent_doc_number] => 07977059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-12
[patent_title] => '17867, a novel human aminopeptidase'
[patent_app_type] => utility
[patent_app_number] => 12/129509
[patent_app_country] => US
[patent_app_date] => 2008-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25032
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/977/07977059.pdf
[firstpage_image] =>[orig_patent_app_number] => 12129509
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/129509 | 17867, a novel human aminopeptidase | May 28, 2008 | Issued |
Array
(
[id] => 6451316
[patent_doc_number] => 20100145131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'METHODS AND KITS FOR PREDICTING CANCER METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 12/451184
[patent_app_country] => US
[patent_app_date] => 2008-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15385
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20100145131.pdf
[firstpage_image] =>[orig_patent_app_number] => 12451184
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/451184 | METHODS AND KITS FOR PREDICTING CANCER METASTASIS | Apr 30, 2008 | Abandoned |
Array
(
[id] => 5270985
[patent_doc_number] => 20090074761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Therapeutic beta-glucan combinations'
[patent_app_type] => utility
[patent_app_number] => 12/150049
[patent_app_country] => US
[patent_app_date] => 2008-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14190
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074761.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150049
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150049 | Therapeutic beta-glucan combinations | Apr 23, 2008 | Abandoned |
Array
(
[id] => 5289994
[patent_doc_number] => 20090022724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/148929
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21126
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022724.pdf
[firstpage_image] =>[orig_patent_app_number] => 12148929
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148929 | Attractin/mahogany-like polypeptides | Apr 21, 2008 | Issued |
Array
(
[id] => 6485656
[patent_doc_number] => 20100093000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Tyrosine phosphorylation sites'
[patent_app_type] => utility
[patent_app_number] => 12/148550
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 36331
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093000.pdf
[firstpage_image] =>[orig_patent_app_number] => 12148550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148550 | Tyrosine phosphorylation sites | Apr 17, 2008 | Abandoned |
Array
(
[id] => 4720115
[patent_doc_number] => 20080242638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'INDUCTION OF DIFFERENTIAL STRESS RESISTANCE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/058600
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 39124
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242638.pdf
[firstpage_image] =>[orig_patent_app_number] => 12058600
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/058600 | Induction of differential stress resistance and uses thereof | Mar 27, 2008 | Issued |
Array
(
[id] => 5569350
[patent_doc_number] => 20090252728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS'
[patent_app_type] => utility
[patent_app_number] => 12/050895
[patent_app_country] => US
[patent_app_date] => 2008-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 74
[patent_no_of_words] => 110427
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20090252728.pdf
[firstpage_image] =>[orig_patent_app_number] => 12050895
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/050895 | NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS | Mar 17, 2008 | Abandoned |
Array
(
[id] => 5508030
[patent_doc_number] => 20090081237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents'
[patent_app_type] => utility
[patent_app_number] => 12/075162
[patent_app_country] => US
[patent_app_date] => 2008-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 31521
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081237.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075162
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075162 | Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents | Mar 9, 2008 | Abandoned |
Array
(
[id] => 10621663
[patent_doc_number] => 09340601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Splice variants of the EGF receptor'
[patent_app_type] => utility
[patent_app_number] => 12/040329
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 20630
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12040329
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/040329 | Splice variants of the EGF receptor | Feb 28, 2008 | Issued |
Array
(
[id] => 4677160
[patent_doc_number] => 20080214791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'MONOCLONAL ANTIBODIES TO HUMAN HIGH MOLECULAR WEIGHT-MELANOMA ASSOCIATED ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 12/039282
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2102
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214791.pdf
[firstpage_image] =>[orig_patent_app_number] => 12039282
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/039282 | Monoclonal antibodies to human high molecular weight-melanoma associated antigen | Feb 27, 2008 | Issued |
Array
(
[id] => 11409198
[patent_doc_number] => 09556491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'Utility of B-RAF DNA mutation in diagnosis and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 12/037798
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8717
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12037798
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/037798 | Utility of B-RAF DNA mutation in diagnosis and treatment of cancer | Feb 25, 2008 | Issued |
Array
(
[id] => 4866873
[patent_doc_number] => 20080145932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'METHOD AND APPARATUS FOR CELL RECOVERY'
[patent_app_type] => utility
[patent_app_number] => 12/030270
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6056
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145932.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030270
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030270 | METHOD AND APPARATUS FOR CELL RECOVERY | Feb 12, 2008 | Abandoned |
Array
(
[id] => 6589119
[patent_doc_number] => 20100062012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Negative Genetic Regulation of Cancer Cell Renewal in Synergy with Notch- or Numb-Specific Immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 12/529759
[patent_app_country] => US
[patent_app_date] => 2008-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19086
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062012.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529759
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529759 | Negative Genetic Regulation of Cancer Cell Renewal in Synergy with Notch- or Numb-Specific Immunotherapy | Feb 7, 2008 | Abandoned |
Array
(
[id] => 5270992
[patent_doc_number] => 20090074768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Activin-actriia antagonists and uses for treating or preventing breast cancer'
[patent_app_type] => utility
[patent_app_number] => 12/012510
[patent_app_country] => US
[patent_app_date] => 2008-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19794
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074768.pdf
[firstpage_image] =>[orig_patent_app_number] => 12012510
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/012510 | Activin-actriia antagonists and uses for treating or preventing breast cancer | Jan 31, 2008 | Issued |
Array
(
[id] => 6584917
[patent_doc_number] => 20100047830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING CANCERS IN A SUBJECT'
[patent_app_type] => utility
[patent_app_number] => 12/523271
[patent_app_country] => US
[patent_app_date] => 2008-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5256
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047830.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523271
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523271 | COMPOSITIONS AND METHODS FOR DETECTING CANCERS IN A SUBJECT | Jan 30, 2008 | Abandoned |
Array
(
[id] => 6464490
[patent_doc_number] => 20100190662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'METHODS AND MATERIALS FOR DETECTION, DIAGNOSIS AND MANAGEMENT OF OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/524537
[patent_app_country] => US
[patent_app_date] => 2008-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8492
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190662.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524537
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524537 | METHODS AND MATERIALS FOR DETECTION, DIAGNOSIS AND MANAGEMENT OF OVARIAN CANCER | Jan 24, 2008 | Abandoned |
Array
(
[id] => 10050826
[patent_doc_number] => 09090693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease'
[patent_app_type] => utility
[patent_app_number] => 12/449129
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14490
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12449129
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/449129 | Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease | Jan 23, 2008 | Issued |